Skip to main content

Advertisement

SpringerLink
Log in

RETRACTED ARTICLE: The effect of chemokine CC motif ligand 19 on the proliferation and migration of hepatocellular carcinoma

  • Research Article
  • Published:
Tumor Biology

This article was retracted on 20 April 2017

Abstract

Multiple studies have shown that CC motif chemokine ligand 19 (CCL19) promotes cell proliferation in several human cancers. The aim of this study was to investigate the expression and function of CCL19 in hepatocellular carcinoma (HCC). Quantitative reverse transcription-polymerase chain reaction (qRT-PCR), Western blot, and immunohistochemistry were performed separately to detect the expression of CCL19 in HCC tissues. The expression of CCL19 and its receptor (CCR7) in different HCC cell lines were screened by Western blot. HCC cell lines were screened and processed with recombinant human CCL19 (rhCCL19) or si-CCL19 RNA. Cell proliferation assay and transwell assay were performed to evaluate the proliferation and migration of HCC cells, respectively. Low expression of CCL19 was observed in 83.72 % (72/86) of the HCC versus 16.67 % (4/24) of the adjacent non-tumorous liver tissues, the difference of CCL19 expression between HCC and adjacent non-tumorous liver tissues was statistically significant (P < 0.001). The expression level of CCL19 mRNA and protein in tumor tissues was significantly lower than adjacent non-tumorous liver tissues. The proliferation and migration of HCC cells were obviously inhibited in rhCCL19-treated groups. Our data suggest that CCL19 may play a suppressive role in the regulation of aggressiveness in human HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Google Scholar 

  2. Ades S. Adjuvant chemotherapy for colon cancer in the elderly: moving from evidence to practice. Oncology (Williston Park). 2009;23:162–7.

    Google Scholar 

  3. Frangov T, Gaĭdarski R, Dimitrova V, Popov V, Grozeva K, Rusenov D. Prognostic factors for survival in primary liver cancer. Khirurgiia (Sofiia). 2007;6:36–9.

    Google Scholar 

  4. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.

    Article  CAS  Google Scholar 

  5. Roussos ET, Condeelis JS, Patsialou A. Chemotaxis in cancer. Nat Rev Cancer. 2011;11:573–87.

    Article  CAS  Google Scholar 

  6. Dieu MC, Vanbervliet B, Vicari A, et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med. 1998;188:373–86.

    Article  CAS  Google Scholar 

  7. Hamanishi J, Mandai M, Matsumura N, et al. Activated local immunity by CC chemokine ligand19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer. Stem Cells. 2010;28:164–73.

    Article  CAS  Google Scholar 

  8. Johrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R. Tumour-immune cell interaction smodulated by chemokines. Expert Opin Biol Ther. 2008;8:269–90.

    Article  Google Scholar 

  9. Wang W, Huang P, Zhang L, Wei J, Xie Q, Sun Q, et al. Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo. Cancer Sci. 2013;104:1523–31.

    Article  CAS  Google Scholar 

  10. Gao Q, Zhao YJ, Wang XY, Qiu SJ, Shi YH, Sun J, et al. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. Cancer Res. 2012;72:3546–56.

    Article  CAS  Google Scholar 

  11. Itakura M, Terashima Y, Shingyoji M, et al. High CC chemokine receptor 7 expression improves postoperative prognosis of lung adenocarcinoma patients. Br J Cancer. 2013;109:1100–8.

    Article  CAS  Google Scholar 

  12. Cao M, Deng HX, Zhao J, Fan LY, Jiang Y, Wen YJ, et al. Antitumour activity of cationic-liposome-conjugated adenovirus containing the CCL19 [chemokine (C-C motif) ligand 19] gene. Biotechnol Appl Biochem. 2007;48:109–16.

    Article  CAS  Google Scholar 

  13. Lu J, Zhao J, Feng H, Wang P, Zhang Z, Zong Y, et al. Antitumor efficacy of CC motif chemokine ligand 19 in colorectal cancer. Dig Dis Sci. 2014;59(9):2153–62.

  14. Oliveira-Neto HH, de Souza PP, da Silva MR, Mendonça EF, Silva TA, Batista AC. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis. Tumour Biol. 2013;34:65–70.

    Article  CAS  Google Scholar 

  15. Shang ZJ, Liu K, Shao Z. Expression of chemokine receptor CCR7 is associated with cervical lymphnode metastasis of oral squamous cell carcinoma. Oral Oncol. 2009;45:48–55.

    Article  Google Scholar 

  16. Kochetkova M, Kumar S, McColl S. R: Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells. Cell Death Differ. 2009;16:664–73.

    Article  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Emergency, SunYat-Sen memorial Hospital, Sun Yat-Sen University, No. 107 yan-jiangxi Road, Guangzhou, 510120, China

    Ke-qin Luo, Yi-ni Shi & Ji-cai Peng

Authors
  1. Ke-qin Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi-ni Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ji-cai Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ke-qin Luo.

Additional information

The Publisher and Editor retract this article in accordance with the recommendations of the Committee on Publication Ethics (COPE). After a thorough investigation we have strong reason to believe that the peer review process was compromised.

An erratum to this article can be found online at http://dx.doi.org/10.1007/s13277-017-5487-6.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, Kq., Shi, Yn. & Peng, Jc. RETRACTED ARTICLE: The effect of chemokine CC motif ligand 19 on the proliferation and migration of hepatocellular carcinoma. Tumor Biol. 35, 12575–12581 (2014). https://doi.org/10.1007/s13277-014-2578-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2578-5

Keyword

Search

Navigation